Aspen Biosciences Newsletter – Closing Out 2024 and Looking Ahead

Aspen Biosciences Newsletter – Closing Out 2024 and Looking Ahead

As we close out 2024, we’re proud to share the milestones and advancements that have helped us empower the drug discovery community to achieve greater efficiency, reduce costs, and accelerate innovation. This year, we expanded the capabilities of our Pipeline and PharmExchange platforms with new modules and features designed to address the evolving needs of biotech and pharmaceutical companies.


Major Highlights of 2024

New Modules:

  • PharmExchange Expansion: Building on the success of our 2023 launch, PharmExchange now supports new workflows for Chemistry and Assay Request Management. These enhancements make it easier than ever for biotech teams to collaborate with CROs and streamline their request management processes.
  • Chemistry Module: Launched at SLAS 2024, this module integrates compound synthesis workflows with inventory management, enabling requests for internal teams or CROs. Scientists can now parallelize tasks, speeding up discovery timelines.
  • Planning Module: Launched at the Why Summits Project & Portfolio Management conference in June, the Planning module empowers teams to create Target Product Profiles (TPPs), assay plans, milestones, and more. It transforms planning into actionable workflows, reducing bottlenecks and improving decision-making.

New Features:

  • Calculation Engine Integration: This versatile tool enables AI/ML-driven workflows, custom calculations, and enhanced scripting capabilities. Already live in our Chemistry module, it will soon be rolled out across other key modules, including Registration, Inventory, and Project Management.

These advancements reinforce our mission to improve the capital efficiency of drug discovery efforts, allowing companies to allocate resources more effectively and maximize their R&D investments.


Key Insights from Our Blog

Throughout the year, we’ve shared insights and strategies for overcoming challenges in drug discovery. Here are some must-read highlights:

  1. Boosting R&D Productivity: Explore how companies can leverage metadata and AI-driven tools to enhance research efficiency. Read more.
  2. Making CRO Collaborations Cost-Effective: Discover how PharmExchange helps teams reduce the complexity and cost of working with CROs. Read more.
  3. Streamlining Request Management Workflows: Learn how our ARM module simplifies assay requests and tracks progress in real-time. Read more.
  4. Starting with the End in Mind: See how early planning with TPPs and assay cascades can increase the likelihood of success. Read more.
  5. Why GRIDALL is a Game-Changer for Project Planning: Uncover how this powerful tool helps align research efforts with strategic objectives. Read more.


Client Success Stories

This year, our solutions drove measurable improvements for clients in biotech and pharma. Here’s a glimpse at the impact:

  • Optimized Assay Management: A biotech firm improved productivity and transparency using Pipeline’s ARM module, reducing errors and accelerating research timelines.
  • Streamlined Protein Production Workflows: With PharmExchange, a fast-growing company expanded its pipeline from 3 to 15 programs while maintaining quality and efficiency.
  • Enhanced Planning Processes: Using Pipeline’s Planning module, a pharma team reduced project delays, optimized resource allocation, and saved costs by identifying risks early.

Want to learn more? Check out our case studies here.


Looking Ahead to 2025

As we step into 2025, our focus remains on enabling breakthrough innovations in drug discovery. With planned updates to the Calculation Engine, continued module expansions, and deeper integrations with AI/ML capabilities, we’re committed to helping research organizations thrive in a competitive landscape.

We’d love to help you take your R&D operations to the next level. Contact us today at [email protected] to explore how our solutions can transform your workflows.

Thank you for being a part of our journey. Here’s to another year of innovation and collaboration!

要查看或添加评论,请登录

Aspen Biosciences的更多文章

社区洞察